The rapid growth in IT technology is leading to the development of new type of medicine known as the digital therapeutics that may change the way the patient is treated. With an ‘OK’ from the Global health regulators, digital therapies have already proved to be efficient in treating neuropsychiatric disorders and drug addictions that were challenging to conventional treatments. According to the Biotech Policy Research Center, the market for digital therapeutics in the U.S. is expected to grow from $850 million in 2017 to $4.42 billion in 2023. Various companies are gearing up to explore the field of digital therapeutics to deal with unmet medical needs.
Source: Korea Biomedical Review